February 21, 2018 / 10:24 PM / 8 months ago

BRIEF-Clovis Oncology Receives Positive Trend Vote In European Regulatory Review Ovarian Cancer Treatment

Feb 21 (Reuters) - Clovis Oncology Inc:

* CLOVIS ONCOLOGY RECEIVES POSITIVE TREND VOTE FROM CHMP IN EUROPEAN REGULATORY REVIEW FOR RUCAPARIB OVARIAN CANCER TREATMENT INDICATION

* CLOVIS ONCOLOGY INC - PENDING A POSITIVE RECOMMENDATION BY CHMP FOR RUCAPARIB TABLETS, FINAL APPROVAL BY EUROPEAN COMMISSION WOULD FOLLOW IN Q2 2018 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below